Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ryoko Okutani
Alectinib Resistance in ALK-rearranged Lung Cancer by Dual Salvage Signaling in a Clinically Paired Resistance Model
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Related publications
Molecular Mechanisms of Resistance to First- And Second-Generation ALK Inhibitors in ALK-rearranged Lung Cancer
European Journal of Cancer
Cancer Research
Oncology
Personalized Medicine Tackles Clinical Resistance: Alectinib in ALK-Positive Non-Small Cell Lung Cancer Progressing on First-Generation ALK Inhibitor
Clinical Cancer Research
Cancer Research
Oncology
P1.01-009 Clinically Primary and Secondary Resistance to ALK Inhibitors in ALK-Positive Advanced Non-Small-Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Therapeutic Decision Based on Molecular Detection of Resistance Mechanism in an ALK-rearranged Lung Cancer Patient: A Case Report
OncoTargets and Therapy
Oncology
Pharmacology
Serial Liquid Biopsies for Detection of Treatment Failure and Profiling of Resistance Mechanisms in KLC1-ALK Rearranged Lung Cancer
Cold Spring Harbor molecular case studies
Biochemistry
Molecular Medicine
Genetics
Pcn172 - Cost-Effectiveness Analysis of Alectinib in Untreated Alk-Rearranged NSCLC Italian Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Nicotinic-nAChR Signaling Mediates Drug Resistance in Lung Cancer
Journal of Cancer
Oncology
Dramatic Response to Alectinib in a Lung Cancer Patient With a Novel VKORC1L1-ALK Fusion and an Acquired ALK T1151K Mutation
Lung Cancer: Targets and Therapy
Oncology
Drug Resistance in Lung Cancer
Lung Cancer: Targets and Therapy
Oncology
